Literature DB >> 30144686

Islet microRNAs in health and type-2 diabetes.

Anna Wendt1, Jonathan Ls Esguerra1, Lena Eliasson2.   

Abstract

Failure of the β-cell to secrete enough insulin is a major contributing factor in the pathogenesis of type-2 diabetes (T2D). MicroRNAs provide an extra layer in the regulation of protein expression, and are thus involved in β-cell compensation during development of the disease. In this review, we discuss how microRNAs can regulate their target protein expression and phenotypic output, present the status of nutritional regulation of microRNA expression, and summarize work on microRNA expression in human islets. In conclusion, current data lend support to microRNAs being essential regulators of insulin secretion. Future work will describe microRNAs in α-cell function, details of the microRNA-mRNA network, and possibilities to use microRNAs as biomarkers and in therapeutic treatment of T2D and complications.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30144686     DOI: 10.1016/j.coph.2018.08.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  9 in total

1.  Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery.

Authors:  Gjendine Voss; Anders Edsjö; Anders Bjartell; Yvonne Ceder
Journal:  RNA       Date:  2021-08-25       Impact factor: 4.942

Review 2.  Extracellular Vesicles: A Potential Novel Regulator of Obesity and Its Associated Complications.

Authors:  Ahlee Kim; Amy S Shah; Takahisa Nakamura
Journal:  Children (Basel)       Date:  2018-11-15

Review 3.  Epigenetics in Human Obesity and Type 2 Diabetes.

Authors:  Charlotte Ling; Tina Rönn
Journal:  Cell Metab       Date:  2019-04-11       Impact factor: 27.287

4.  Fetal malnutrition-induced catch up failure is caused by elevated levels of miR-322 in rats.

Authors:  Takahiro Nemoto; Yoshihiko Kakinuma
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

Review 5.  Long Non-Coding RNAs (lncRNAs) in Cardiovascular Disease Complication of Type 2 Diabetes.

Authors:  Nurruzanna Ismail; Noraidatulakma Abdullah; Nor Azian Abdul Murad; Rahman Jamal; Siti Aishah Sulaiman
Journal:  Diagnostics (Basel)       Date:  2021-01-19

6.  Monocyte miRNAs Are Associated With Type 2 Diabetes.

Authors:  Daniel C Parker; Ma Wan; Kurt Lohman; Li Hou; Anh Tram Nguyen; Jingzhong Ding; Alain Bertoni; Steve Shea; Gregory L Burke; David R Jacobs; Wendy Post; David Corcoran; Ina Hoeschele; John S Parks; Yongmei Liu
Journal:  Diabetes       Date:  2022-04-01       Impact factor: 9.461

7.  MiR-574-3p inhibits glucose toxicity-induced pancreatic β-cell dysfunction by suppressing PRMT1.

Authors:  Lixia Lv; Xiumin Wang; Jinhua Shen; Ying Cao; Qin Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-07-15       Impact factor: 5.395

8.  The highly expressed calcium-insensitive synaptotagmin-11 and synaptotagmin-13 modulate insulin secretion.

Authors:  Jones K Ofori; Alexandros Karagiannopoulos; Mohammad Barghouth; Mototsugu Nagao; Markus E Andersson; Vishal A Salunkhe; Enming Zhang; Anna Wendt; Lena Eliasson
Journal:  Acta Physiol (Oxf)       Date:  2022-07-02       Impact factor: 7.523

Review 9.  Advances in oligonucleotide drug delivery.

Authors:  Thomas C Roberts; Robert Langer; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2020-08-11       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.